Celsa C, Cabibbo G, Fulgenzi CAM, Battaglia S, et al. Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment. Hepatology 2024 Jul 19. doi: 10.1097/HEP.0000000000001026.
PMID: 39028886